HIMS
Hims & Hers Health, Inc.
NYSE · Healthcare · Medical - Equipment & Services · US
$28.18
+9.65%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$25.92
From 52W high−35.56%
Volume4.35M
Market cap$6.57B
P/E (TTM)—
P/S (TTM)2.6x
Div yield—
Key dataNov 4, 2026
Open
$25.92
From 52W high
−35.56%
Volume
4.35M
Market cap
$6.57B
ValuationView details →
P/E (Fwd)
81.3x
EV/EBITDA
−95.3x
P/E (TTM)
—
RSI (14)
39.4
MomentumView details →
1D Return
+9.65%
YTD Return
−20.71%
SummaryUpdated Jun 1, 2026
Hims & Hers Health, Inc. (NYSE:HIMS) is a San Francisco-based telehealth company that operates a multi-specialty digital health platform connecting consumers directly to licensed healthcare professionals. Founded in 2017, the company went public in 2019 and has rapidly expanded from its initial focus on men's sexual health to become a comprehensive telehealth provider serving over 2.4 million subscribers across multiple health specialties including weight management, dermatology, mental health, and sexual wellness.
Similar companies
Latest newsMore news →
Law Offices of Frank R. Cruz announced a class action lawsuit against Hims & Hers Health, Inc. on behalf of investors who acquired its securities from August 4, 2025, to July 29, 2026.5d agoHims & Hers Health closed at $29.69, up 1.24% from the previous trading day.6d agoHims & Hers Health shares closed at $27.71, down 4.87% from the previous trading session.12d ago